Aeluma trust sells 100,000 shares valued at $1.14M
The notice also identifies prior 10b5-1 sales by the trust and Jonathan Klamkin.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aeluma, Inc. (ALMU) reported that the Klamkin Drelle Gelasca Family Trust dated August 28, 2025 executed a sale of 100,000 common shares on October 12, 2026, with a reported aggregate market value of $1,140,000. The notice also lists earlier 10b5-1 sales: 100,000 shares for $1,335,320 by the trust on September 21, 2026, and 20,000 shares for $334,642 by Jonathan Klamkin on August 3, 2026.
Key Figures
Key Terms
Rule 144 regulatory
10b5-1 Sales financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.